Cigna Investments’s Bio-Techne TECH Stock Holding History

Cigna Investments’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,756	Closed	-$298K	–	566
2022 Q1	$298K	Sell	2,756 -788	-22%	-$81.3K	0.04%	446
2021 Q4	$459K	Sell	3,544 -1,440	-29%	-$177K	0.04%	397
2021 Q3	$603K	Hold	4,984	–	–	0.05%	378
2021 Q2	$562K	Sell	4,984 -800	-14%	-$84.2K	0.04%	399
2021 Q1	$552K	Buy	5,784 +72	+1%	+$6.57K	0.04%	421
2020 Q4	$454K	Buy	5,712 +484	+9%	+$35.1K	0.04%	438
2020 Q3	$323K	Hold	5,228	–	–	0.03%	466
2020 Q2	$345K	Sell	5,228 -11,476	-69%	-$687K	0.03%	504
2020 Q1	$792K	Sell	16,704 -9,336	-36%	-$467K	0.1%	217
2019 Q4	$1.37M	Sell	26,040 -856	-3%	-$44.9K	0.14%	180
2019 Q3	$1.4M	Buy	26,896 +400	+2%	+$20.1K	0.14%	174
2019 Q2	$1.39M	Buy	26,496 +22,012	+491%	+$1.11M	0.15%	168
2019 Q1	$222K	Buy	+4,484	New	+$202K	0.02%	616
2018 Q4	–	Sell	-4,800	Closed	-$202K	–	762
2018 Q3	$202K	Buy	+4,800	New	+$213K	0.02%	693
2018 Q2	–	Sell	-6,348	Closed	-$240K	–	800
2018 Q1	$240K	Buy	+6,348	New	+$224K	0.02%	717

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return

Cigna Investments's TECH Position: Q2 2022 in Review

Cigna Investments sold out of Bio-Techne (TECH) in Q2 2022, closing a stake of 2,756 shares — an estimated $298K sold.

Cigna Investments first reported a position in TECH in Q1 2018 and held it in 15 quarters. The position peaked at $1.4M in Q3 2019. 550 funds tracked by Wall St. Rank hold TECH as of Q2 2022.

Cigna Investments reported no remaining Bio-Techne position as of Q2 2022 after selling out during the quarter.
Cigna Investments sold 2,756 Bio-Techne shares in Q2 2022, an estimated $298K.
Cigna Investments first reported a position in Bio-Techne in Q1 2018 and held it in 15 quarters.
Cigna Investments's Bio-Techne position peaked at $1.4M in Q3 2019.
550 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2022.

Based on Cigna Investments's 13F filing for Q2 2022, filed 15 Aug 2022.